Patients' views of treatment: methadone vs. buprenorphine

White, Rupert, Beazley, Peter ORCID: https://orcid.org/0000-0001-8821-1213, Thompson, Michelle, Charnaud, Ben, Cox, David and Griffiths, Vanessa (2007) Patients' views of treatment: methadone vs. buprenorphine. Journal of Substance Use, 12 (5). pp. 365-373. ISSN 1465-9891

Full text not available from this repository.

Abstract

Introduction: Buprenorphine is being used increasingly as an alternative treatment to methadone in the treatment of heroin misuse. Aim: We sought to obtain patients' views regarding the two medications and test the hypothesis that buprenorphine has a better reputation and is therefore preferred by patients. Method: Patients receiving treatment in Cornwall, UK were asked to complete a 34‐item questionnaire. Results: One‐hundred‐and‐thirty‐five questionnaires were returned. Methadone was considered superior in the domain relating to mental health, but buprenorphine was judged as better in other domains. The ease with which buprenorphine is diverted was highlighted. Overall, methadone was preferred, so refuting our hypothesis, but the differences were marginal. Discussion: Patient preference alone does not justify the increased of cost of buprenorphine. However, for the sake of increasing patient choice it would seem important that it is available.

Item Type: Article
Uncontrolled Keywords: sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Depositing User: LivePure Connector
Date Deposited: 12 Jan 2023 09:30
Last Modified: 16 Jan 2023 01:53
URI: https://ueaeprints.uea.ac.uk/id/eprint/90524
DOI: 10.1080/14659890701289463

Actions (login required)

View Item View Item